Oral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes: a randomized, double-blind, placebo-controlled trial
科研动态Nature Medicine
2026-09-29
Abstract Safiglipron is an oral small-molecule glucagon-like peptide-1 (GLP-1) receptor agonist administered without fas…
原文：Nature Medicine（本页为平台整理的中文摘要，逐句对照原文核对后发布）